Patrick Healy, a Senior Biopharma Executive with a Successful Track Record in Clinical Trials Development, joins Aviceda Therapeutics as Chief Operations Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics, a private company located in Cambridge, MA with a Phase II ready ophthalmic lead product for geographic atrophy (GA) secondary to dry AMD (dAMD) announced, today, Patrick Healy, founding CEO of Trial Runners, will join their management team consisting of Key Opinion Leaders in the field of Ophthalmology. Mr. Healy is joining Aviceda as Chief Operations Officer and Senior Vice-President. He joins Drs. Mohamed Genead (CEO), David Callanan (